Gleason Score for Prostate Cancer
The Gleason score grades prostate cancer aggressiveness by adding the two predominant histologic patterns on biopsy.
Indications for Use
Start by grading biopsy cores using primary + secondary Gleason patterns to classify tumor differentiation and aggressiveness 1 [Level III evidence]. Clinical utility includes risk stratification (low, intermediate, high) informing treatment intensity, prognosis (higher scores predict metastasis and mortality), and guiding management such as active surveillance vs. radical therapy 2 [Level II evidence].
Insights & Cautions
Predicts tumor aggressiveness and risk of recurrence or metastasis; higher patterns (especially pattern 4/5) drive prognosis per NCCN validation cohorts (>26,000 men) showing sharp declines in 5‑yr recurrence‑free survival across Grade Groups 1→5 1 [Level I evidence]. Caution: biopsy undergrading, especially hidden pattern 4/5; tertiary pattern 5 confers risk similar to Gleason 8–10 2 [Level II evidence]. Interobserver variability persists.